JOINT FILING AGREEMENT
Exhibit 1
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of July 11, 2022, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Provention Bio, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
By: | /s/ Xxxx Xxxxx | |
Xxxx Xxxxx | ||
Xxxx Xxxxx, individually, as manager of Xxxxx Capital GP, LLC, the general partner of Xxxxx Capital (Master), L.P., and as manager of Xxxxx Capital IM GP, LLC, the general partner of Xxxxx Capital IM, L.P. | ||
Date: | July 11, 2022 |